HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The management of central neurocytoma: radiotherapy.

Abstract
Intraventricular neurocytomas (IVNs) are rare tumors of neuronal differentiation, accounting for 0.1% to 0.5% of all primary brain tumors. Complete surgical resection is highly recommended, but at least one-third to one-half are subtotally resected. Stereotactic radiosurgery (SRS) and conventional radiotherapy have been used for management of residual and recurrent tumors, but the optimal treatment following subtotal surgical resection is less clear. Although there are trends toward higher local tumor control and survival rates with lower complications among IVNs treated with SRS, higher quality data are required to confirm these findings.
AuthorsIgor J Barani, David R Raleigh, David Larson
JournalNeurosurgery clinics of North America (Neurosurg Clin N Am) Vol. 26 Issue 1 Pg. 45-56 (Jan 2015) ISSN: 1558-1349 [Electronic] United States
PMID25432183 (Publication Type: Comparative Study, Journal Article, Review)
CopyrightCopyright © 2015 Elsevier Inc. All rights reserved.
Topics
  • Brain Neoplasms (radiotherapy, surgery)
  • Humans
  • Neoplasm Recurrence, Local (pathology)
  • Neurocytoma (radiotherapy, surgery)
  • Radiosurgery (methods)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: